Skip to main content

Equibles does not estimate personal net worth.

Get an email with a short summary when Sangamo Therapeutics, Inc publishes a filing, an earnings call transcript or a press release.

Get SGMOQ alerts

About Phillip Ramsey

Sangamo Therapeutics, Inc reported in an 8-K filed April 26, 2023 that Phillip Ramsey was appointed Head of Technical Operations, effective May 29, 2023. Sangamo Therapeutics, Inc is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Sangamo Therapeutics, Inc includes Alexander D. Macrae (CEO and Board Member), Kathy Y. Yi (CFO), Nikunj Jain (CFO and Chief Accounting Officer) and 7 others.

“Phillip Ramsey, currently serving as Vice President, Technical Development, has been appointed as Head of Technical Operations effective May 29, 2023.”
Sangamo Therapeutics, Inc Form 8-K, filed April 26, 2023 · Read the filing

Affiliation history

Company network

Leadership on record at Sangamo Therapeutics, Inc

Recent activity